INSYS Therapeutics (INSY) Decline Appers Overdone - Wells Fargo
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
INSYS Therapeutics (INSY) Stock Declines on Reports of Doctor Fraud
May 9, 2014 4:36 PM EDTINSYS Therapeutics (Nasdaq: INSY) stock tanked on reports a doctor in Michigan has been accused of defrauding Medicare by $7 million. The doctor is accused of writing 1,283 million prescriptions for Subsys in 5 years, 20.3% of Subsys prescribed to Medicare beneficiaries nationwide during this... More
